Cognitive Impairment in Convalescent COVID-19 Patients Undergoing Multidisciplinary Rehabilitation: The Association with the Clinical and Functional Status.
COVID-19
cognitive impairment
disability
exercise
occupational medicine
outcome
rehabilitation
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
04 Mar 2022
04 Mar 2022
Historique:
received:
26
01
2022
revised:
01
03
2022
accepted:
01
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Cognitive impairment has been reported in the aftermath of severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection. We investigated the possible association between cognitive impairment and the main clinical and functional status variables in a cohort of convalescent COVID-19 patients without premorbid diseases potentially affecting cognition. We consecutively screened for inclusion of convalescent COVID-19 patients referring to a post-acute care facility for pulmonary rehabilitation. All the enrolled patients were assessed for cognitive functions. We also investigated features of psychological distress (anxiety, depression, symptoms of posttraumatic stress disorder and quality of life) and cardiac and pulmonary functional status. The 63 enrolled patients (mean age 59.82 ± 10.78, male gender = 47) showed a high frequency of depressive symptoms (76.2%) and anxiety (55.5%), and a high prevalence of symptoms of posttraumatic stress disorder (PTSD, 44.4%). About half of the total sample showed reduced cognitive efficiency (RCE, 44.4%) in the domains of spatial and verbal long-term memory and executive functions. Patients with RCE more frequently showed alteration of blood pressure (BP) circadian rhythm ( Our findings indicated a possible association between the RCE after COVID-19 and some cardiological variables, including some indirect measures of a residual autonomic disorder, such as the presence of an altered BP circadian rhythm. Future research studies with large samples are needed to provide valid conclusions.
Sections du résumé
BACKGROUND
BACKGROUND
Cognitive impairment has been reported in the aftermath of severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection. We investigated the possible association between cognitive impairment and the main clinical and functional status variables in a cohort of convalescent COVID-19 patients without premorbid diseases potentially affecting cognition.
METHODS
METHODS
We consecutively screened for inclusion of convalescent COVID-19 patients referring to a post-acute care facility for pulmonary rehabilitation. All the enrolled patients were assessed for cognitive functions. We also investigated features of psychological distress (anxiety, depression, symptoms of posttraumatic stress disorder and quality of life) and cardiac and pulmonary functional status.
RESULTS
RESULTS
The 63 enrolled patients (mean age 59.82 ± 10.78, male gender = 47) showed a high frequency of depressive symptoms (76.2%) and anxiety (55.5%), and a high prevalence of symptoms of posttraumatic stress disorder (PTSD, 44.4%). About half of the total sample showed reduced cognitive efficiency (RCE, 44.4%) in the domains of spatial and verbal long-term memory and executive functions. Patients with RCE more frequently showed alteration of blood pressure (BP) circadian rhythm (
CONCLUSIONS
CONCLUSIONS
Our findings indicated a possible association between the RCE after COVID-19 and some cardiological variables, including some indirect measures of a residual autonomic disorder, such as the presence of an altered BP circadian rhythm. Future research studies with large samples are needed to provide valid conclusions.
Identifiants
pubmed: 35326958
pii: healthcare10030480
doi: 10.3390/healthcare10030480
pmc: PMC8950669
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ital J Neurol Sci. 1996 Aug;17(4):305-9
pubmed: 8915764
Games Health J. 2020 Oct;9(5):311-313
pubmed: 32876489
J Sleep Res. 2021 Dec 28;:e13542
pubmed: 34964184
Ann Intern Med. 2007 Oct 16;147(8):W163-94
pubmed: 17938389
Postgrad Med J. 2021 Jul;97(1149):469-470
pubmed: 32753565
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Brain Behav Immun Health. 2020 Dec;9:100163
pubmed: 33111132
Thorax. 2006 Sep;61(9):744-6
pubmed: 16936234
Brain Inj. 2006 Oct;20(11):1139-45
pubmed: 17123930
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86
pubmed: 26623686
Neurol Sci. 2005 Jun;26(2):108-16
pubmed: 15995827
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):405-12
pubmed: 19479171
Brain Behav. 2021 Jul;11(7):e02166
pubmed: 33969636
Neuroepidemiology. 2021;55(2):79-91
pubmed: 33756479
Nat Sci Sleep. 2022 Jan 24;14:93-108
pubmed: 35115852
J Clin Exp Neuropsychol. 1997 Dec;19(6):795-809
pubmed: 9524875
Brain Behav Immun. 2021 Jan;91:383-392
pubmed: 33148439
PLoS One. 2021 Feb 8;16(2):e0246590
pubmed: 33556127
Lancet Neurol. 2005 Aug;4(8):487-99
pubmed: 16033691
BMJ Open. 2021 Dec 13;11(12):e050672
pubmed: 34903540
Neurol Sci. 2019 Mar;40(3):469-477
pubmed: 30535956
Clin Neuropsychol. 2020 Oct - Nov;34(7-8):1453-1479
pubmed: 32901580
Rev Cardiovasc Med. 2020 Sep 30;21(3):315-319
pubmed: 33070537
PLoS One. 2020 Oct 14;15(10):e0239570
pubmed: 33052920
Neurol Sci. 2014 Mar;35(3):365-72
pubmed: 23963806
Int J Environ Res Public Health. 2020 Nov 28;17(23):
pubmed: 33260777
Neurol Sci. 2013 Jun;34(6):971-8
pubmed: 22903771
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Neurol Sci. 2016 May;37(5):681-91
pubmed: 27032401
Virusdisease. 2021 Mar;32(1):146-149
pubmed: 33614860
Brain Sci. 2021 Feb 13;11(2):
pubmed: 33668456
Lancet Neurol. 2021 Oct;20(10):854-867
pubmed: 34536406
Age (Dordr). 2012 Oct;34(5):1295-308
pubmed: 21853262
Front Physiol. 2021 May 19;12:630038
pubmed: 34093217
Brain Commun. 2020 Nov 23;2(2):fcaa205
pubmed: 33376990
Eur Neurol. 1996;36(6):378-84
pubmed: 8954307
J Neurol Sci. 2021 Jan 15;420:117271
pubmed: 33359928
Monaldi Arch Chest Dis. 2012 Sep;78(3):155-9
pubmed: 23614330
Lancet. 1988 Aug 13;2(8607):397
pubmed: 2899801
Eur Neuropsychopharmacol. 2021 May;46:39-48
pubmed: 33823427
Arch Neurol. 2007 Dec;64(12):1734-40
pubmed: 18071036
Metabolism. 2020 Dec;113:154378
pubmed: 33002478
Front Aging Neurosci. 2016 Dec 12;8:301
pubmed: 28018214
JAMA Neurol. 2020 Aug 1;77(8):1018-1027
pubmed: 32469387
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
Eur Geriatr Med. 2020 Oct;11(5):857-862
pubmed: 32666303
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937